By: Sarah Dickey, ACA Membership Director

Investors and entrepreneurs from the Pacific Northwest and around the world will reunite in Portland and online May 4-6 for ACA 2021 - The Summit of Angel Investing! 

By: Sarah Dickey, ACA Membership Director

The programming team for ACA 2021 - The Summit of Angel Investing is full of experienced, respected angel investors and ecosystem providers, and they are hard at work creating a virtual experience that will change the way you think about angel investing. 

By: Bridget Weston, CEO of SCORE

If you are an entrepreneur building a small business, you know that it takes more than spreadsheets, financial projections, and a big marketing push to reach business success; it also takes passion, dedication, and attention to detail. 

By: Amy Duncan, Fund Manager - San Diego Angel Conference (SDAC) III

The number of accredited angel investors in the U.S. has held steady at around 300,000 for the last ten years. Based on the definition of an accredited angel of a net worth of $1 million or more, the potential number of angel investors could be up to four million. As angels are typically characterized as making individual investments between $25,000-500,000 in early-stage companies, it’s likely that many who are qualified have a lower risk appetite. 

By: Matt McMahon, Director – SEED (Small business Education and Entrepreneurial Development), National Institutes of Health

The National Institutes of Health (NIH) is proud to be an Angel Capital Association Platinum Partner. NIH supports a dynamic portfolio of 1,500 cutting edge small businesses with over a billion dollars of non-dilutive investment every year. Angel investors can partner with NIH to help NIH-funded small businesses bring their products and services to the healthcare marketplace, where they can improve health and save lives. 

John Guy, Manager, Emerging Companies Section Policy at Biotechnology Innovation Organization

Five years ago today, the Protecting Americans from Tax Hikes (PATH) Act was signed into law. This important piece of legislation included several provisions helpful to start ups like small biotechs, including permanently extending both the R&D Credit and the Small Business Stock Gains Exclusion (Tax Code Section 1202), providing both investors and the companies they invest in security without worry of losing access to the critical incentive in the future. 

By: Elaine Bolle, RTP Capital Associates

Rob Neville is a serial entrepreneur, and his story is a powerful testimonial about the importance of angel funding. 

By: Warren Spiwak, IBTX Partner

ACA Affinity Partner IBTX recognizes the risk that angels and startups face.  Now during these unique and extremely challenging times, these risks are more complex then ever before.  IBTX Partner Warren Spiwak recently sat down with ACA to discuss what angels need to be aware of and what the IBTX team of dedicated risk management professionals can do to create innovative solutions to fit the unique needs of the startup ecosystem. 

By: Dror Futter, Legal and Business Adviser to Startups, Venture Capital Firms and Technology Companies

The SEC announced a series of amendments (likely to be effective early next year) to the rules governing private offering exemptions – by far the most frequent path for venture fundraising.  The amendments retain the same “menu” of exemptions but make incremental improvements. For the early stage community, the amendments include a very useful provision that excludes “Demo Days” from being considered general solicitations provided certain conditions are met. 

By: Russ Krajec, CEO of BlueIron

Due diligence is essential for any business deal, and IP due diligence is shockingly left out of the equation for most angel investors and venture capital investors.